🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase I trial studies the side effects and best dose of AR-42 when giv...
Status
Completed
Location
Cincinnati Children's Hospital
Start Date
2013-09-17
Trial ID
NCT01798901
Treatments Being Tested
Quisinostat besides its own efficacy, which can potentially lead to better ...
Status
Completed
Location
Russian Oncological Research Center n.a. N. N. Blokhin RAMS
Start Date
2013-08
Trial ID
NCT02728492
Treatments Being Tested
The purpose of this study is to test the safety of a combination of two ant...
Status
Completed
Location
Center for Lymphoid Malignancies at CUMC
Start Date
2008-06
Trial ID
NCT00691210
Treatments Being Tested
The purpose of the study is to find out the effects and the safety of an in...
Status
Terminated
Location
H. Lee Moffitt Cancer Center and Research Institute
Start Date
2010-03
Trial ID
NCT01090973
Treatments Being Tested
BACKGROUND: * The histone deacetylase (HDAC) inhibitors are a novel class ...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2009-07-01
Trial ID
NCT00926640
Treatments Being Tested
A histone deacetylase (HDAC) inhibitor is a class of drug that interferes w...
Status
Terminated
Location
University of North Carolina Memorial Hospital
Start Date
2006-06
Trial ID
NCT00312546
Treatments Being Tested
Primary objective: To evaluate the efficacy of two different dosing schedul...
Status
Completed
Location
Multiple Locations
Start Date
2004-12
Trial ID
NCT00185302
The purpose of this study is to see the safety and activity of using pasire...
Status
Completed
Location
Emory University Winship Cancer Institute
Start Date
2011-12
Trial ID
NCT01469572
Treatments Being Tested
This phase I/II trial is studying the side effects and best dose of azaciti...
Status
Completed
Location
USC Norris Comprehensive Cancer Center
Start Date
2006-08
Trial ID
NCT00387465
Treatments Being Tested
This study will be a two-arm prospective 1:1 randomised controlled trial co...
Status
Completed
Location
Brighton and Sussex University Hospitals NHS Trust
Start Date
2015-11-27
Trial ID
NCT02336074